Richter Takes Control Of German JVs To Wrap Up Teriparatide Biosimilar

Majority Owned CDMO With Three Sites Also Set To Move Into Richter’s Hands

 
• By Dean Rudge
  
Generate a summary of this article
Listen to this article
Beta

Gedeon Richter is putting its hand back in its wallet following its recent investment in Formycon, opting to take control of a pair of joint ventures established with German firm Helm.

old abacus with bills of 500 euros close up

Hungarian player Gedeon Richter has struck agreements worth more than €100m ($109m) to buy out a couple of joint ventures from its long-term German partner Helm, including a JV (Richter-Helm BioLogics) that owns the Terrosa (teriparatide) biosimilar to Forteo/Forsteo, in a move it believes will “create a very strong biotechnology platform allowing even better service offerings in a cost-efficient way.”

Through a €71.8m purchase agreement, Richter is seeking to buy out Helm’s 50% stake in Richter-Helm BioTec GmbH & Co....

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

Nexus Faces Five Year Wait On Injectable Minocycline

Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.

Top 10 Drugs Q1 2026: New Sheriff In Town As Mounjaro Unseats Keytruda - Clone - Clone

Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains

test

uygukgigo

 
• By Saba Afreen

More from Business

UK Invests £28m In NHS AI, But Industry Says Procurement And Training Will Determine Success - C8

 
• By Reed Miller

The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.

UK Invests £28m In NHS AI, But Industry Says Procurement And Training Will Determine Success

 
• By Reed Miller

The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.

Top 10 Drugs Q1 2026: New Sheriff In Town As Mounjaro Unseats Keytruda - Clone - Clone

Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains